An in vivo replication-important function in the second coding exon of Tat is constrained against mutation despite cytotoxic T lymphocyte selection

被引:44
作者
Smith, SM [1 ]
Pentlicky, S
Klase, Z
Singh, M
Neuveut, C
Lu, CY
Reitz, MS
Yarchoan, R
Marx, PA
Jeang, KT
机构
[1] St Michaels Hosp, Newark, NJ 07102 USA
[2] Univ Med & Dent New Jersey, Newark, NJ 07102 USA
[3] Inst Pasteur, Unite Recombinaison & Express, F-75015 Paris, France
[4] NIAID, Mol Virol Sect, NIH, Bethesda, MD 20892 USA
[5] Univ Maryland, Inst Biotechnol, Inst Human Virol, Baltimore, MD 21201 USA
[6] NCI, HIV & AIDS Malignancy Branch, Div Clin Sci, NIH, Bethesda, MD 20892 USA
[7] Tulane Univ, Hlth Sci Ctr, Dept Trop Med, Covington, LA 70433 USA
[8] Tulane Natl Primate Res Ctr, Covington, LA 70433 USA
关键词
D O I
10.1074/jbc.M307546200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human and simian immunodeficiency virus (HIV/SIV) Tat proteins are specified by two coding exons. Tat functions in the transcription of primate lentiviruses. A plethora of in vitro data currently suggests that the second coding exon of Tat is largely devoid of function. However, whether the second exon of Tat contributes functionally to viral pathogenesis in vivo remains unknown. To address this question directly, we compared infection of rhesus macaques with an SIV, engineered to express only the first coding exon of Tat (SIVtat1ex), to counterpart infection with wild-type SIVmac239 virus, which expresses the full 2-exon Tat. This comparison showed that the second coding exon of Tat contributes to chronic SIV replication in vivo. Interestingly, in macaques, we observed a cytotoxic T lymphocytes (CTL) response to the second coding exon of Tat, which appears to durably control SIV replication. When SIV mutated in an attempt to escape this second Tat-exon-CTL, the resulting virus was less replicatively fit and failed to populate the host in vivo. Our study provides the first evidence that the second coding exon in Tat embodies an important function for in vivo replication. We suggest the second coding exon of Tat as an example of a functionally constrained "epitope" whose elicited CTL response cannot be escaped by virus mutation without producing a virus that replicates poorly in vivo.
引用
收藏
页码:44816 / 44825
页数:10
相关论文
共 56 条
  • [1] The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals
    Addo, MM
    Altfeld, M
    Rosenberg, ES
    Eldridge, RL
    Philips, MN
    Habeeb, K
    Khatri, A
    Brander, C
    Robbins, GK
    Mazzara, GP
    Goulder, PJR
    Walker, BD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) : 1781 - 1786
  • [2] A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice
    Agwale, SM
    Shata, MT
    Reitz, MS
    Kalyanaraman, VS
    Gallo, RC
    Popovic, M
    Hone, DM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (15) : 10037 - 10041
  • [3] Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication
    Allen, TM
    Mortara, L
    Mothé, BR
    Liebl, M
    Jing, PC
    Calore, B
    Piekarczyk, M
    Ruddersdorf, R
    O'Connor, DH
    Wang, X
    Wang, CX
    Allison, DB
    Altman, JD
    Sette, A
    Desrosiers, RC
    Sutter, G
    Watkins, DI
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (08) : 4108 - 4112
  • [4] Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
    Allen, TM
    O'Connor, DH
    Jing, PC
    Dzuris, JL
    Mothé, BR
    Vogel, TU
    Dunphy, E
    Liebl, ME
    Emerson, C
    Wilson, N
    Kunstman, KJ
    Wang, XC
    Allison, DB
    Hughes, AL
    Desrosiers, RC
    Altman, JD
    Wolinsky, SM
    Sette, A
    Watkins, DI
    [J]. NATURE, 2000, 407 (6802) : 386 - 390
  • [5] Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
    Amara, RR
    Villinger, F
    Altman, JD
    Lydy, SL
    O'Neil, SP
    Staprans, SI
    Montefiori, DC
    Xu, Y
    Herndon, JG
    Wyatt, LS
    Candido, MA
    Kozyr, NL
    Earl, PL
    Smith, JM
    Ma, HL
    Grimm, BD
    Hulsey, ML
    Miller, J
    McClure, HM
    McNicholl, JM
    Moss, B
    Robinson, HL
    [J]. SCIENCE, 2001, 292 (5514) : 69 - 74
  • [6] Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys
    Barouch, DH
    Kunstman, J
    Glowczwskie, J
    Kunstman, KJ
    Egan, MA
    Peyerl, FW
    Santra, S
    Kuroda, MJ
    Schmitz, JE
    Beaudry, K
    Krivulka, GR
    Lifton, MA
    Gorgone, DA
    Wolinsky, SM
    Letvin, NL
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (13) : 7367 - 7375
  • [7] Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
    Barouch, DH
    Kunstman, J
    Kuroda, MJ
    Schmitz, JE
    Santra, S
    Peyerl, FW
    Krivulka, GR
    Beaudry, K
    Lifton, MA
    Gorgone, DA
    Montefiori, DC
    Lewis, MG
    Wolinsky, SM
    Letvin, NL
    [J]. NATURE, 2002, 415 (6869) : 335 - 339
  • [8] BOOTH J, 1998, 16 ANN S NONH PRIM M
  • [9] VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    BORROW, P
    LEWICKI, H
    HAHN, BH
    SHAW, GM
    OLDSTONE, MBA
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (09) : 6103 - 6110
  • [10] Boucher C, 1996, AIDS, V10, pS15